Get 20% lifetime commission for referring investors to digrin.com
here.
XORTX Therapeutics Inc. (XRTX) Financials
XRTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 4.9 million | 407458 |
| 2023-06-30 | 5.9 million | 304623 |
| 2023-03-31 | 12.4 million | 5.4 million |
| 2022-12-31 | 12.4 million | 5.4 million |
XRTX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -793216 | 16077 |
| 2023-06-30 | -1.3 million | 23242 |
| 2023-03-31 | -3.8 million | 71140 |
| 2022-12-31 | -3.8 million | 70978 |
XRTX Net Income
No data available :(
XRTX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 3.7 million | - | 20979 |
| 2023-06-30 | 4.7 million | - | 34132 |
| 2023-03-31 | 10.4 million | - | 45484 |
| 2022-12-31 | 10.4 million | - | 77510 |
XRTX Shares Outstanding
XRTX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 5370 | 419199 | 375342 | - |
| 2023-06-30 | 7205 | 504541 | 545627 | - |
| 2023-03-31 | 16024 | 1.9 million | 514587 | - |
| 2022-12-31 | 15988 | 1.9 million | 513411 | - |
XRTX Cost of Revenue
No data available :(
XRTX
Price: $2.50
52 week price:
Earnings Per Share: -1.09 USD
P/E Ratio: -5.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 45600
Market Capitalization: 7.8 million